Oesophageal Cancer Clinical Trial
Official title:
DEPISTORL - THANCS (Trial of Head And Neck Cancer Screening) Randomized Multicenter Trial to Assess the Impact of a Screening Program for Heavy Alcohol Drinkers and Smokers Treated in Alcohol Addiction Clinics on Upper Aerodigestive Tract Cancer Mortality.
Verified date | May 2017 |
Source | Gustave Roussy, Cancer Campus, Grand Paris |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Randomized multicenter trial to assess the impact of a screening program for heavy alcohol drinkers and smokers treated in alcohol addiction clinics on upper aerodigestive tract cancer mortality.
Status | Completed |
Enrollment | 1993 |
Est. completion date | December 18, 2015 |
Est. primary completion date | December 18, 2015 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 40 Years and older |
Eligibility |
Inclusion Criteria: - current or previous heavy smokers (smoked >= 20 years) and alcohol drinkers who need specialized care Exclusion Criteria: - Head and neck clinical examination during the past 6 months - History of squamous cell carcinoma of the upper aero-digestive tract. - Recent digestive hemorrhage from varicose esophagus |
Country | Name | City | State |
---|---|---|---|
France | Centre Hospitalier MONTPERRIN | Aix en Provence | |
France | CHIAB Annemasse Bonneville | Annemasse | |
France | Centre Hospitalier d'ARRAS | Arras | |
France | CHS de L'Yonne | Auxerre | |
France | Chg Beziers | Beziers | |
France | C.A.S.A. | Clermont | |
France | CHU Hôpital Gabriel Montpied | Clermont-ferrand | |
France | Centre Hospitalier de DIEPPE | Dieppe | |
France | CHU le Bocage | Dijon | |
France | Centre Hospitalier Louis Sevestre | La Membrolle Sur Choisille | |
France | Centre Hospitalier du Mans | Le Mans | |
France | Centre Hospitalier de LENS | Lens | |
France | CHU de Lille | Lille | |
France | CHBS Lorient | Lorient | |
France | Centre hospitalier Lyon sud | Lyon | |
France | Centre Hospitalier des Chanaux | Macon | |
France | CHU de Nancy | Nancy | |
France | CHU de Nantes | Nantes | |
France | Hôpital ARCHET II | Nice | |
France | Centre ANPAA d'Orléans | Orléans | |
France | Centre Paul Cézanne | Orléans | |
France | Hôpital de la Source | Orléans | |
France | Clinique Philae | Pont Pean | |
France | Centre Hospitalier du Centre Bretagne | Pontivy | |
France | Centre ANPAA 51 de Reims | Reims | |
France | CHU Hôpital Pontchaillou | Rennes | |
France | Hopital de Saint Cloud | Saint Cloud | |
France | CHR de la Réunion | Saint-denis de La Reunion | |
France | Ch Saint-Egreve | Saint-egreve | |
France | Centre de soins de suite Marienbronn | Soultz-sous-forets | |
France | CHU de Strasbourg - Hôpital Hautepierre | Strasbourg | |
France | Hôpitaux du Leman | Thonon Les Bains | |
France | Chba Vannes | Vannes | |
France | Hopital Paul Brousse | Villejuif | |
France | Institut_Gustave-Roussy | Villejuif |
Lead Sponsor | Collaborator |
---|---|
Gustave Roussy, Cancer Campus, Grand Paris |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Upper aerodigestive tract cancer mortality | 5 years | ||
Secondary | Screening test morbidity | 1 week | ||
Secondary | Upper aerodigestive tract cancer incidence | 5 years | ||
Secondary | Upper aerodigestive tract cancer stage | 5 years |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05685862 -
Laser Speckle Contrast Imaging, Surgical Eye & ICG Fluorescence Imaging for Perfusion Assessment of the Gastric Conduit
|
||
Recruiting |
NCT01795768 -
Proof-of-Concept Study of AZD4547 in Patients With FGFR1 or FGFR2 Amplified Tumours
|
Phase 2 | |
Completed |
NCT05266300 -
Implementation and Quality Assurance of DPYD-genotyping in Patients Treated With Fluoropyrimidines.
|
||
Recruiting |
NCT03978377 -
Cardiopulmonary Toxicity of Thoracic Radiotherapy
|
||
Active, not recruiting |
NCT03653052 -
Do Changes in ctDNA Predict Response for Patients With Oesophageal Cancer Receiving Durvalumab
|
Phase 2 | |
Recruiting |
NCT05489250 -
The PLATON Network
|
||
Recruiting |
NCT04484636 -
PLATON - Platform for Analyzing Targetable Tumor Mutations (Pilot-study)
|
N/A | |
Terminated |
NCT01795976 -
NY-ESO-1 T Cells in OG Cancer
|
Phase 2 | |
Recruiting |
NCT01843829 -
A Feasibility Study of Chemo-radiotherapy to Treat Operable Oesophageal Cancer
|
Phase 2 | |
Completed |
NCT02382237 -
Comparison of Tumor Glucose Metabolism Before and After Artificial Nutrition
|
N/A | |
Completed |
NCT01915693 -
ROCS (Radiotherapy After Oesophageal Cancer Stenting) Study
|
Phase 3 | |
Recruiting |
NCT04517448 -
Quality of Life of Patients Over 75 Yars Undergoing Palliative Chemotherapy
|
||
Recruiting |
NCT04232735 -
Evidence Based Information Provision to Improve Decision Making After Oesophagogastric Cancer Diagnosis (SOURCE)
|
N/A | |
Recruiting |
NCT05642819 -
REVOLUTION Surgery (REVOLUTION Surgery)
|
||
Recruiting |
NCT04001478 -
Non-invasive Testing for Early oEesophageal Cancer and Dysplasia
|
||
Recruiting |
NCT02741856 -
Study of Chemoradiotherapy in Oesophageal Cancer Including PET Response and Dose Escalation
|
Phase 2/Phase 3 | |
Not yet recruiting |
NCT05600608 -
Augmentation of Volatile Biomarkers of Oesophageal and Gastric Adenocarcinoma From the Tumour Lipidome
|
N/A | |
Recruiting |
NCT04481256 -
TGF-β And PDL-1 Inhibition in Esophageal Squamous Cell Carcinoma Combined With Chemoradiation TheRapY
|
N/A | |
Recruiting |
NCT05057013 -
HMBD-001 in Advanced HER3 Positive Solid Tumours
|
Phase 1/Phase 2 | |
Not yet recruiting |
NCT06046846 -
Prehabilitation Via a Mobile Application in Oesophago-gastric Cancer
|
N/A |